Shanghai Junshi Biosciences Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 380.8 million compared to CNY 255.15 million a year ago. Revenue was CNY 380.8 million compared to CNY 255.15 million a year ago.

Net loss was CNY 283.03 million compared to CNY 543.43 million a year ago. Basic loss per share from continuing operations was CNY 0.29 compared to CNY 0.55 a year ago. Diluted loss per share from continuing operations was CNY 0.29 compared to CNY 0.55 a year ago.